annual EBITDA:
$20.00M+$10.05M(+100.95%)Summary
- As of today (July 6, 2025), HROW annual EBITDA is $20.00 million, with the most recent change of +$10.05 million (+100.95%) on December 31, 2024.
- During the last 3 years, HROW annual EBITDA has risen by +$15.74 million (+369.66%).
- HROW annual EBITDA is now at all-time high.
Performance
HROW EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$6.32M-$23.77M(-136.24%)Summary
- As of today (July 6, 2025), HROW quarterly EBITDA is -$6.32 million, with the most recent change of -$23.77 million (-136.24%) on March 31, 2025.
- Over the past year, HROW quarterly EBITDA has dropped by -$1.35 million (-27.24%).
- HROW quarterly EBITDA is now -136.24% below its all-time high of $17.45 million, reached on December 31, 2024.
Performance
HROW quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$18.65M-$1.35M(-6.77%)Summary
- As of today (July 6, 2025), HROW TTM EBITDA is $18.65 million, with the most recent change of -$1.35 million (-6.77%) on March 31, 2025.
- Over the past year, HROW TTM EBITDA has increased by +$14.16 million (+315.16%).
- HROW TTM EBITDA is now -6.77% below its all-time high of $20.00 million, reached on December 31, 2024.
Performance
HROW TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HROW EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +101.0% | -27.2% | +315.2% |
| 3 y3 years | +369.7% | -2201.0% | +486.8% |
| 5 y5 years | +948.4% | +46.0% | +191.2% |
HROW EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +744.8% | -136.2% | at low | -6.8% | +701.2% |
| 5 y | 5-year | at high | +744.8% | -136.2% | at low | -6.8% | +191.2% |
| alltime | all time | at high | +240.8% | -136.2% | +46.0% | -6.8% | +183.6% |
HROW EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$6.32M(-136.2%) | $18.65M(-6.8%) |
| Dec 2024 | $20.00M(+101.0%) | $17.45M(+273.6%) | $20.00M(+1778.2%) |
| Sep 2024 | - | $4.67M(+63.7%) | $1.06M(-56.8%) |
| Jun 2024 | - | $2.85M(-157.4%) | $2.46M(-45.1%) |
| Mar 2024 | - | -$4.97M(+233.8%) | $4.49M(-54.9%) |
| Dec 2023 | $9.95M(-420.9%) | -$1.49M(-124.5%) | $9.95M(-34.9%) |
| Sep 2023 | - | $6.07M(+24.4%) | $15.30M(+182.5%) |
| Jun 2023 | - | $4.88M(+892.1%) | $5.41M(-286.0%) |
| Mar 2023 | - | $492.00K(-87.2%) | -$2.91M(-6.2%) |
| Dec 2022 | -$3.10M(-172.8%) | $3.85M(-201.1%) | -$3.10M(-221.1%) |
| Sep 2022 | - | -$3.81M(+10.7%) | $2.56M(+765.5%) |
| Jun 2022 | - | -$3.44M(-1244.2%) | $296.00K(-90.7%) |
| Mar 2022 | - | $301.00K(-96.8%) | $3.18M(-25.4%) |
| Dec 2021 | $4.26M(+22.0%) | $9.52M(-256.6%) | $4.26M(-616.9%) |
| Sep 2021 | - | -$6.08M(+981.5%) | -$824.00K(-105.5%) |
| Jun 2021 | - | -$562.00K(-140.7%) | $15.09M(-9.0%) |
| Mar 2021 | - | $1.38M(-68.8%) | $16.57M(+374.8%) |
| Dec 2020 | $3.49M(+83.0%) | $4.43M(-54.9%) | $3.49M(-2007.7%) |
| Sep 2020 | - | $9.83M(+963.0%) | -$183.00K(-99.1%) |
| Jun 2020 | - | $925.00K(-107.9%) | -$20.45M(-8.3%) |
| Mar 2020 | - | -$11.70M(-1639.6%) | -$22.31M(-1269.3%) |
| Dec 2019 | $1.91M(-156.6%) | $760.00K(-107.3%) | $1.91M(-434.2%) |
| Sep 2019 | - | -$10.43M(+1013.4%) | -$571.00K(-105.9%) |
| Jun 2019 | - | -$937.00K(-107.5%) | $9.70M(-7.4%) |
| Mar 2019 | - | $12.52M(-828.2%) | $10.47M(-410.2%) |
| Dec 2018 | -$3.37M(-67.6%) | -$1.72M(+929.3%) | -$3.37M(+0.6%) |
| Sep 2018 | - | -$167.00K(+0.6%) | -$3.35M(-38.8%) |
| Jun 2018 | - | -$166.00K(-87.4%) | -$5.48M(-30.9%) |
| Mar 2018 | - | -$1.32M(-22.2%) | -$7.92M(-23.8%) |
| Dec 2017 | -$10.40M(-26.6%) | -$1.70M(-25.8%) | -$10.40M(-11.6%) |
| Sep 2017 | - | -$2.29M(-12.3%) | -$11.76M(-11.9%) |
| Jun 2017 | - | -$2.61M(-31.2%) | -$13.35M(-7.2%) |
| Mar 2017 | - | -$3.80M(+23.9%) | -$14.39M(+1.5%) |
| Dec 2016 | -$14.17M(-0.3%) | -$3.06M(-21.1%) | -$14.17M(-9.4%) |
| Sep 2016 | - | -$3.88M(+6.4%) | -$15.64M(+3.5%) |
| Jun 2016 | - | -$3.65M(+1.9%) | -$15.12M(+2.2%) |
| Mar 2016 | - | -$3.58M(-21.1%) | -$14.80M(+4.1%) |
| Dec 2015 | -$14.21M | -$4.54M(+35.1%) | -$14.21M(+14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$3.36M(+0.8%) | -$12.39M(+8.0%) |
| Jun 2015 | - | -$3.33M(+11.3%) | -$11.47M(+7.0%) |
| Mar 2015 | - | -$2.99M(+10.1%) | -$10.72M(+6.5%) |
| Dec 2014 | -$10.06M(+31.7%) | -$2.72M(+11.5%) | -$10.06M(+9.1%) |
| Sep 2014 | - | -$2.44M(-5.4%) | -$9.23M(+4.1%) |
| Jun 2014 | - | -$2.58M(+10.5%) | -$8.87M(+4.2%) |
| Mar 2014 | - | -$2.33M(+24.0%) | -$8.50M(+11.4%) |
| Dec 2013 | -$7.64M(+42.6%) | -$1.88M(-9.5%) | -$7.64M(+5.9%) |
| Sep 2013 | - | -$2.08M(-6.4%) | -$7.21M(+13.0%) |
| Jun 2013 | - | -$2.22M(+51.4%) | -$6.38M(+16.8%) |
| Mar 2013 | - | -$1.46M(+0.9%) | -$5.46M(+2.0%) |
| Dec 2012 | -$5.36M(+509.6%) | -$1.45M(+16.6%) | -$5.36M(+28.9%) |
| Sep 2012 | - | -$1.25M(-4.3%) | -$4.16M(+39.6%) |
| Jun 2012 | - | -$1.30M(-4.2%) | -$2.98M(+63.4%) |
| Mar 2012 | - | -$1.36M(+436.8%) | -$1.82M(+107.4%) |
| Dec 2011 | -$878.60K(-64.5%) | -$252.90K(+280.3%) | -$878.70K(-12.7%) |
| Sep 2011 | - | -$66.50K(-54.4%) | -$1.01M(-39.7%) |
| Jun 2011 | - | -$145.70K(-64.8%) | -$1.67M(-17.4%) |
| Mar 2011 | - | -$413.60K(+8.8%) | -$2.02M(-18.5%) |
| Dec 2010 | -$2.47M(-45.6%) | -$380.20K(-47.7%) | -$2.47M(-13.5%) |
| Sep 2010 | - | -$727.50K(+46.5%) | -$2.86M(-6.6%) |
| Jun 2010 | - | -$496.50K(-43.0%) | -$3.06M(-19.3%) |
| Mar 2010 | - | -$870.50K(+13.7%) | -$3.80M(-16.6%) |
| Dec 2009 | -$4.55M(+21.5%) | -$765.80K(-17.6%) | -$4.55M(-4.2%) |
| Sep 2009 | - | -$929.00K(-24.5%) | -$4.75M(+2.0%) |
| Jun 2009 | - | -$1.23M(-24.4%) | -$4.66M(-1.1%) |
| Mar 2009 | - | -$1.63M(+68.8%) | -$4.71M(+25.6%) |
| Dec 2008 | -$3.75M(+31.0%) | -$964.10K(+15.5%) | -$3.75M(-13.6%) |
| Sep 2008 | - | -$834.40K(-34.8%) | -$4.34M(+70.5%) |
| Jun 2008 | - | -$1.28M(+92.0%) | -$2.54M(+101.3%) |
| Mar 2008 | - | -$667.00K(-57.1%) | -$1.26M(+111.2%) |
| Dec 2007 | -$2.86M(>+9900.0%) | -$1.55M(-260.3%) | -$598.10K(-170.3%) |
| Sep 2007 | - | $969.10K(-9508.7%) | $851.00K(-820.6%) |
| Aug 2007 | - | -$10.30K(+836.4%) | -$118.10K(+9.6%) |
| May 2007 | - | -$1100.00(-42.1%) | -$107.80K(+1.0%) |
| May 2007 | -$13.60K | - | - |
| Feb 2007 | - | -$1900.00(-98.2%) | -$106.70K(+1.8%) |
| Nov 2006 | - | -$104.80K | -$104.80K |
FAQ
- What is Harrow Health annual EBITDA?
- What is the all time high annual EBITDA for Harrow Health?
- What is Harrow Health annual EBITDA year-on-year change?
- What is Harrow Health quarterly EBITDA?
- What is the all time high quarterly EBITDA for Harrow Health?
- What is Harrow Health quarterly EBITDA year-on-year change?
- What is Harrow Health TTM EBITDA?
- What is the all time high TTM EBITDA for Harrow Health?
- What is Harrow Health TTM EBITDA year-on-year change?
What is Harrow Health annual EBITDA?
The current annual EBITDA of HROW is $20.00M
What is the all time high annual EBITDA for Harrow Health?
Harrow Health all-time high annual EBITDA is $20.00M
What is Harrow Health annual EBITDA year-on-year change?
Over the past year, HROW annual EBITDA has changed by +$10.05M (+100.95%)
What is Harrow Health quarterly EBITDA?
The current quarterly EBITDA of HROW is -$6.32M
What is the all time high quarterly EBITDA for Harrow Health?
Harrow Health all-time high quarterly EBITDA is $17.45M
What is Harrow Health quarterly EBITDA year-on-year change?
Over the past year, HROW quarterly EBITDA has changed by -$1.35M (-27.24%)
What is Harrow Health TTM EBITDA?
The current TTM EBITDA of HROW is $18.65M
What is the all time high TTM EBITDA for Harrow Health?
Harrow Health all-time high TTM EBITDA is $20.00M
What is Harrow Health TTM EBITDA year-on-year change?
Over the past year, HROW TTM EBITDA has changed by +$14.16M (+315.16%)